Purpose: To evaluate the impact on the radiation protection policies of the radiocontaminants in Samarium-153 ethylenediamine tetramethylene phosphonate ((153)Sm-EDTMP).
Methods: The internal contamination of patients treated with (153)Sm-EDMTP for palliation of painful disseminated multiple bone metastases due to long-lived impurities was assessed by direct measurements. These measurements were coupled with dose-rate measurements close to their bodies and spectroscopic analysis of the residual activity in post-treatment radiopharmaceutical vials.
Results: Whole-body counting carried out in six patients showed a 30-81-kBq europium -152 plus europium-154 contamination. The 0.85 mean (152)Eu- to -(154)Eu activity ratio obtained by direct counting was similar to that assessed by analysis of post-treatment residual activities in twelve radiopharmaceutical vials following radiopharmaceutical injection.
Conclusions: The long-lived radiocontaminants in the patient's bodies and the treatment wastes require modifications of the applicable radiation protection policies.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.ejmp.2014.10.078 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!